ÂÜÀòÂÒÂ×

Debrup Chakraborty, M.Sc, Ph.D, currently serves as Scientist III at Inotiv, focusing on drug discovery and translational sciences while leading teams and managing business innovation. Prior experience includes positions at The Ohio State University, where as a Research Scientist, significant contributions were made to understanding colon cancer metastasis and establishing collaborative project management practices. Earlier roles include Senior Research Associate at Michigan State University, where efforts centered on cancer prevention and pharmacological drug development, and postdoctoral research at Cornell University and Henry Ford Health System, contributing to studies on metabolic diseases and prostate cancer. Educational qualifications include a Ph.D. in in vivo toxicology and cell biology from the University of Kalyani, complemented by postdoctoral training at Cornell University.